Editorial Commentary

Affiliations

¹ Division of Urology, Department of Surgery, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey.
² Dow Division of Health Services, Department of Urology, University of Michigan, Ann Arbor, Michigan.

Comment

Raeesa Islam et al. Urol Pract. 2025 Jan.

. 2025 Jan;12(1):129.

doi: 10.1097/UPJ.0000000000000694. Epub 2024 Sep 18.

¹ Division of Urology, Department of Surgery, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey.
² Dow Division of Health Services, Department of Urology, University of Michigan, Ann Arbor, Michigan.

No abstract available

Comment on

Contemporary Trends of Benign Prostatic Hyperplasia Procedures in the AUA Quality Registry: Are We Moving the Needle Toward More Minimally Invasive Treatments?
Patel HV, Breyer BN, Jones C, Mbassa R, Meeks W 3rd, Helsel A, Cooperberg MR. Patel HV, et al. Urol Pract. 2025 Jan;12(1):124-129. doi: 10.1097/UPJ.0000000000000691. Epub 2024 Aug 21. Urol Pract. 2025. PMID: 39167566

1. Patel Hiren V., Breyer Benjamin N., Jones Charles et al. “Contemporary Trends of BPH Procedures in the Aqua Registry: Are We Moving the Needle Towards More Minimally Invasive Treatments?” Urology Practice, 2024. - PubMed
1. Sandhu JS, Bixler BR, Dahm P, et al. Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia (BPH): AUA Guideline amendment 2023. J Urol. 2023; 10.1097/JU.0000000000003698 - DOI - PubMed
1. Maganty Avinash, and Hollenbeck Brent K. “New technology in prostate cancer and financial toxicity.” Urologic oncology vol. 41,9 (2023): 376–379. doi:10.1016/j.urolonc.2023.04.014 - DOI - PMC - PubMed